France's Aureus Pharma, a knowledge management provider for the life sciences industry, says it has signed a licensing deal with UK drug major GlaxoSmithKline which grants the latter access to Aureus' AurSCOPE Knowledge databases.
The deal covers several of the Parisian firm's datasets, including information on: AurSCOPE GPCR; Ion Channel hERG; and ADME/Drug-Drug Interactions. In addition, GSK has licensed Aureus AurSCOPE Kinase product for use in the field of oncology. Financial details were not disclosed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze